Dr. Jim Xiang was awarded a CoMRad Grant
Dr. Jim Xiang was awarded a CoMRad grant from the College of Medicine for a project called: "Critical role of FAK/RhoA in regulation of mTORC1/PKM2 pathway controlling epithelial-mesenchymal transition of triple-negative breast cancer".